Veradermics, Inc — Form 10-Q
Filed August 11, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Reid Waldman, M.D. (CEO) and Dominic Carrano, CPA (CFO) issued standard Sarbanes-Oxley Section 302 and 906 certifications on August 11, 2026 for the quarter ended June 30, 2026. Both officers certified that the 10-Q contains no material misstatements, fairly presents financial condition and results of operations, and that disclosure controls and internal controls over financial reporting are effective. No specific business transactions, dollar amounts, or operational changes are disclosed in these certification exhibits.
Why this rating
Routine SOX certifications; boilerplate disclosure requirement with no business substance, transactions, or material events disclosed.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.